Cannabinoid clinical trial appeal

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email



Preliminary studies from the lab suggest that cannabinoid chemicals THC and CBD can stop glioblastoma cells from growing, causing them to die and disrupting the blood supply to the tumour cells. And earlier this year, an early-stage trial in the clinic suggested that adding a specific blend of these chemicals – in the form of a drug called Sativex – to chemotherapy could potentially help treat recurrent GBMs more effectively.

We’re reaching out to all you individual heroes and supporters to help fund a major trial here in the UK to assess whether this drug could give patients more time to live. For the next week (until 10 August), anything you can afford to donate will be worth double in funding towards a clinical trial that needs to start urgently: https://bit.ly/Cannabinoid-BigGive

Learn more: https://thebraintumourcharity.org/cannabinoid-appeal

#CannabinoidTrial #ACureCantWait

View original source video by clicking here

On Key

Related Posts

Knicks Training Camp Day 1

Coach talks about the first day at practice and much more after the first day of training camp. View original source video by clicking here